Denali Therapeutics (4DN.MU) Q2 2026 Earnings

12MayConfirmed
Q1 2026
Next
-0.62
-0.62
-0.62
-0.62

Details

Expected EPS
-0.61789104013
Actual EPS
N/A
Surprise EPS
0.62
Surprise Percent
+100%

Description

Denali Therapeutics (4DN.MU) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts